-葡萄糖共运输体-2 抑制剂对心脏功能的影响和机制:前性队列研究研究的研究方案
Min-Jia Cao1, Fang-Hong Shi1, Bin-Bin Yu2
1Department of Pharmacy, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Frontiers in endocrinology
|August 4, 2023
概括
这项研究调查了-葡萄糖共运输体-2 (SGLT2) 抑制剂是否能在急性心肌梗塞 (AMI) 后改善心脏功能. 它评估2型糖尿病患者的左心室功能和生活质量,探索心脏保护机制.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 急性心肌梗塞 (AMI) 是导致心力衰竭和死亡的主要原因.
- -葡萄糖共运输体-2 (SGLT2) 抑制剂对心血管有好处,但它们在AMI患者中的作用尚不清楚.
- SGLT2 抑制剂的机制,特别是它们对左心室 (LV) 功能的影响,需要进一步研究.
研究的目的:
- 评估SGLT2抑制剂在改善2型糖尿病 (T2DM) AMI患者的LV功能方面的疗效.
- 评估SGLT2抑制剂对该患者群体生活质量和功能能力的影响.
- 探索AMI中SGLT2抑制剂的潜在心脏保护机制.
主要方法:
- 一个前性的,IV期,开放标签,单中心试验,涉及120名患有T2DM的AMI患者.
- 接受SGLT2抑制剂的患者组成实验组;其他人接受标准抗糖尿病药物 (对照组).
- 主要结局:通过心磁共振 (CMR) 在1年内改变LV末缩体积指数 (LVESVi). 二次结果包括LV参数,生活质量 (KCCQ-OS,EQ-5D) 和生物标志物.
主要成果:
- 本部分应在研究完成后填写.
结论:
- 本部分应在研究完成后填写.
相关概念视频
Glucose Transporters
22.9K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.9K
Secondary Active Transport
121.1K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
121.1K
Oral Hypoglycemic Agents: Biguanides and Glitazones
234
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
234
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
206
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
206
Glucose Absorption Into the Small Intestine
31.8K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
31.8K
Heart Failure Drugs: Inotropic Agents
622
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
622


